Literature DB >> 3090660

Physiological and clinical studies of GRF and GH.

M O Thorner, M L Vance, W S Evans, R M Blizzard, A D Rogol, K Ho, D A Leong, J L Borges, M J Cronin, R M MacLeod.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3090660

Source DB:  PubMed          Journal:  Recent Prog Horm Res        ISSN： 0079-9963


× No keyword cloud information.
  6 in total

1.  Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus.

Authors:  L A Frohman; T R Downs; T C Williams; E P Heimer; Y C Pan; A M Felix
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

2.  Growth hormone-releasing hormone: a clinical perspective.

Authors:  R Khardori; P S Menon
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

3.  Immunolike growth hormone substance in tissues from human embryos/fetuses and adults.

Authors:  A Costa; G Zoppetti; C Benedetto; E Bertino; L Marozio; C Fabris; R Arisio; G F Giraudi; O Testori; M Ariano
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

4.  Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma.

Authors:  L A Frohman; T R Downs; E P Heimer; A M Felix
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

5.  New Gaba-containing analogues of human growth hormone releasing hormone (1-30)-amide: II. Detailed in vivo biological examinations.

Authors:  M Kovács; I Mezõ; I Teplán; M Hollósi; J Kajtár; B Flerkó
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

6.  Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients.

Authors:  D R Ciocca; L A Puy; L C Fasoli; O Tello; J C Aznar; F E Gago; S I Papa; R Sonego
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.